{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T19:04:45Z","timestamp":1791313485810,"version":"4.3.1"},"reference-count":65,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,11,28]],"date-time":"2019-11-28T00:00:00Z","timestamp":1574899200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100011264","name":"FP7 People: Marie-Curie Actions","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011264","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002997","name":"Nierstichting","doi-asserted-by":"publisher","award":["17PhD02"],"award-info":[{"award-number":["17PhD02"]}],"id":[{"id":"10.13039\/501100002997","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003246","name":"Nederlandse Organisatie voor Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003246","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["EBioMedicine"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.ebiom.2019.11.046","type":"journal-article","created":{"date-parts":[[2019,12,23]],"date-time":"2019-12-23T23:33:52Z","timestamp":1577144032000},"page":"102585","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"special_numbering":"C","title":["Prioritization of novel ADPKD drug candidates from disease-stage specific gene expression profiles"],"prefix":"10.1016","volume":"51","author":[{"given":"Tareq B.","family":"Malas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wouter N.","family":"Leonhard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hester","family":"Bange","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoraide","family":"Granchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina M.","family":"Hettne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerard J.P.","family":"Van Westen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leo S.","family":"Price","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter A.C.","family":"'t Hoen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorien J.M.","family":"Peters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7607","key":"10.1016\/j.ebiom.2019.11.046_bib0001","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1038\/534314a","article-title":"Can you teach old drugs new tricks?","volume":"534","author":"Nosengo","year":"2016","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.ebiom.2019.11.046_bib0002","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1093\/bib\/bbr013","article-title":"Exploiting drug-disease relationships for computational drug repositioning","volume":"12","author":"Dudley","year":"2011","journal-title":"Brief Bioinform"},{"issue":"5298","key":"10.1016\/j.ebiom.2019.11.046_bib0003","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1126\/science.275.5298.343","article-title":"An information-intensive approach to the molecular pharmacology of cancer","volume":"275","author":"Weinstein","year":"1997","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.ebiom.2019.11.046_bib0004","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0092-8674(03)01070-5","article-title":"Old drugs, new tricks: using genetically sensitized yeast to reveal drug targets","volume":"116","author":"Hughes","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.ebiom.2019.11.046_bib0005","article-title":"In vitro 3d phenotypic drug screen identifies celastrol as an effective in vivo inhibitor of polycystic kidney disease","author":"Booij","year":"2019","journal-title":"J Mol Cell Biol"},{"issue":"5","key":"10.1016\/j.ebiom.2019.11.046_bib0006","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0155811","article-title":"An integrated data driven approach to drug repositioning using gene-disease associations","volume":"11","author":"Mullen","year":"2016","journal-title":"PLoS ONE"},{"issue":"7270","key":"10.1016\/j.ebiom.2019.11.046_bib0007","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/nature08506","article-title":"Predicting new molecular targets for known drugs","volume":"462","author":"Keiser","year":"2009","journal-title":"Nature"},{"issue":"5795","key":"10.1016\/j.ebiom.2019.11.046_bib0008","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1126\/science.1132939","article-title":"The connectivity map: using gene-expression signatures to connect small molecules, genes, and disease","volume":"313","author":"Lamb","year":"2006","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.ebiom.2019.11.046_bib0009","doi-asserted-by":"crossref","first-page":"4412","DOI":"10.1038\/s41467-018-06515-4","article-title":"Expression-based drug screening of neural progenitor cells from individuals with schizophrenia","volume":"9","author":"Readhead","year":"2018","journal-title":"Nat Commun"},{"issue":"6","key":"10.1016\/j.ebiom.2019.11.046_bib0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2017.10.049","article-title":"A next generation connectivity map: L1000 platform and the first 1,000,000 profiles","volume":"171","author":"Subramanian","year":"2017","journal-title":"Cell"},{"issue":"10","key":"10.1016\/j.ebiom.2019.11.046_bib0011","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1681\/ASN.2018050493","article-title":"Prevalence estimates of polycystic kidney and liver disease by population sequencing","volume":"29","author":"Lanktree","year":"2018","journal-title":"J Am Soc Nephrol"},{"issue":"8","key":"10.1016\/j.ebiom.2019.11.046_bib0012","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1093\/ndt\/gfw240","article-title":"Prevalence of autosomal dominant polycystic kidney disease in the European Union","volume":"32","author":"Willey","year":"2017","journal-title":"Nephrol Dial Transplant"},{"issue":"8","key":"10.1016\/j.ebiom.2019.11.046_bib0013","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1002\/humu.22103","article-title":"Autosomal dominant polycystic kidney disease: comprehensive mutation analysis of PKD1 and PKD2 in 700 unrelated patients","volume":"33","author":"Audrezet","year":"2012","journal-title":"Hum Mutat"},{"issue":"Suppl 4","key":"10.1016\/j.ebiom.2019.11.046_bib0014","doi-asserted-by":"crossref","DOI":"10.1093\/ndt\/gfu017","article-title":"Renal replacement therapy for autosomal dominant polycystic kidney disease (ADPKD) in Europe: prevalence and survival\u2013an analysis of data from the ERA-EDTA registry","volume":"29","author":"Spithoven","year":"2014","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.ebiom.2019.11.046_bib0015","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.ebiom.2016.01.027","article-title":"Fatty acid oxidation is impaired in an orthologous mouse model of autosomal dominant polycystic kidney disease","volume":"5","author":"Menezes","year":"2016","journal-title":"EBioMedicine"},{"issue":"6","key":"10.1016\/j.ebiom.2019.11.046_bib0016","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1172\/JCI72272","article-title":"Genetic mechanisms and signaling pathways in autosomal dominant polycystic kidney disease","volume":"124","author":"Harris","year":"2014","journal-title":"J Clin Invest"},{"issue":"9","key":"10.1016\/j.ebiom.2019.11.046_bib0017","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1056\/NEJMoa0907419","article-title":"Sirolimus and kidney growth in autosomal dominant polycystic kidney disease","volume":"363","author":"Serra","year":"2010","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.ebiom.2019.11.046_bib0018","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1056\/NEJMoa1003491","article-title":"Everolimus in patients with autosomal dominant polycystic kidney disease","volume":"363","author":"Walz","year":"2010","journal-title":"N Engl J Med"},{"issue":"9903","key":"10.1016\/j.ebiom.2019.11.046_bib0019","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1016\/S0140-6736(13)61407-5","article-title":"Effect of longacting somatostatin analogue on kidney and cyst growth in autosomal dominant polycystic kidney disease (ALADIN): a randomised, placebo-controlled, multicentre trial","volume":"382","author":"Caroli","year":"2013","journal-title":"Lancet"},{"issue":"25","key":"10.1016\/j.ebiom.2019.11.046_bib0020","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1056\/NEJMoa1205511","article-title":"Tolvaptan in patients with autosomal dominant polycystic kidney disease","volume":"367","author":"Torres","year":"2012","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.ebiom.2019.11.046_bib0021","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.drudis.2014.12.014","article-title":"Using transcriptomics to guide lead optimization in drug discovery projects: lessons learned from the QSTAR project","volume":"20","author":"Verbist","year":"2015","journal-title":"Drug Discov Today"},{"issue":"5","key":"10.1016\/j.ebiom.2019.11.046_bib0022","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.ygeno.2016.04.001","article-title":"RNA-seq analysis of hippocampal tissues reveals novel candidate genes for drug refractory epilepsy in patients with MTLE-HS","volume":"107","author":"Dixit","year":"2016","journal-title":"Genomics"},{"issue":"5","key":"10.1016\/j.ebiom.2019.11.046_bib0023","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1681\/ASN.2011040340","article-title":"Dose-dependent effects of sirolimus on mTOR signaling and polycystic kidney disease","volume":"23","author":"Novalic","year":"2012","journal-title":"J Am Soc Nephrol"},{"issue":"12","key":"10.1016\/j.ebiom.2019.11.046_bib0024","doi-asserted-by":"crossref","first-page":"3589","DOI":"10.1681\/ASN.2015030287","article-title":"Inhibition of activin signaling slows progression of polycystic kidney disease","volume":"27","author":"Leonhard","year":"2016","journal-title":"J Am Soc Nephrol"},{"issue":"14","key":"10.1016\/j.ebiom.2019.11.046_bib0025","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1093\/hmg\/ddp190","article-title":"Toxic tubular injury in kidneys from Pkd1-deletion mice accelerates cystogenesis accompanied by dysregulated planar cell polarity and canonical Wnt signaling pathways","volume":"18","author":"Happe","year":"2009","journal-title":"Hum Mol Genet"},{"issue":"5","key":"10.1016\/j.ebiom.2019.11.046_bib0026","doi-asserted-by":"crossref","first-page":"F1193","DOI":"10.1152\/ajprenal.00419.2010","article-title":"Curcumin inhibits cystogenesis by simultaneous interference of multiple signaling pathways: in vivo evidence from a Pkd1-deletion model","volume":"300","author":"Leonhard","year":"2011","journal-title":"Am J Physiol Renal Physiol"},{"issue":"4","key":"10.1016\/j.ebiom.2019.11.046_bib0027","doi-asserted-by":"crossref","first-page":"R36","DOI":"10.1186\/gb-2013-14-4-r36","article-title":"TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions","volume":"14","author":"Kim","year":"2013","journal-title":"Genome Biol"},{"issue":"7","key":"10.1016\/j.ebiom.2019.11.046_bib0028","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1093\/nar\/gkv007","article-title":"limma powers differential expression analyses for RNA-sequencing and microarray studies","volume":"43","author":"Ritchie","year":"2015","journal-title":"Nucleic Acids Res"},{"issue":"13","key":"10.1016\/j.ebiom.2019.11.046_bib0029","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1093\/hmg\/ddp165","article-title":"Systems biology of autosomal dominant polycystic kidney disease (ADPKD): computational identification of gene expression pathways and integrated regulatory networks","volume":"18","author":"Song","year":"2009","journal-title":"Hum Mol Genet"},{"issue":"Web Server issue","key":"10.1016\/j.ebiom.2019.11.046_bib0030","doi-asserted-by":"crossref","first-page":"W186","DOI":"10.1093\/nar\/gkm323","article-title":"GeneTrail\u2013advanced gene set enrichment analysis","volume":"35","author":"Backes","year":"2007","journal-title":"Nucleic Acids Res"},{"issue":"9","key":"10.1016\/j.ebiom.2019.11.046_bib0031","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1007\/s10822-015-9860-5","article-title":"Activity, assay and target data curation and quality in the chembl database","volume":"29","author":"Papadatos","year":"2015","journal-title":"J Comput Aided Mol Des"},{"issue":"Database issue","key":"10.1016\/j.ebiom.2019.11.046_bib0032","doi-asserted-by":"crossref","first-page":"D563","DOI":"10.1093\/nar\/gkp871","article-title":"Ensembl genomes: extending Ensembl across the taxonomic space","volume":"38","author":"Kersey","year":"2010","journal-title":"Nucleic Acids Res"},{"issue":"Database issue","key":"10.1016\/j.ebiom.2019.11.046_bib0033","doi-asserted-by":"crossref","first-page":"D1100","DOI":"10.1093\/nar\/gkr777","article-title":"ChEMBL: a large-scale bioactivity database for drug discovery","volume":"40","author":"Gaulton","year":"2012","journal-title":"Nucleic Acids Res"},{"issue":"8","key":"10.1016\/j.ebiom.2019.11.046_bib0034","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1177\/2472555217716056","article-title":"High-Throughput phenotypic screening of kinase inhibitors to identify drug targets for polycystic kidney disease","volume":"22","author":"Booij","year":"2017","journal-title":"SLAS Discov"},{"issue":"12","key":"10.1016\/j.ebiom.2019.11.046_bib0035","doi-asserted-by":"crossref","first-page":"3530","DOI":"10.1681\/ASN.2016040425","article-title":"Variable Cyst development in autosomal dominant polycystic kidney disease: the biologic context","volume":"27","author":"Leonhard","year":"2016","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"10.1016\/j.ebiom.2019.11.046_bib0036","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s00109-010-0715-1","article-title":"Formation of cysts by principal-like MDCK cells depends on the synergy of cAMP- and ATP-mediated fluid secretion","volume":"89","author":"Buchholz","year":"2011","journal-title":"J Mol Med (Berl)"},{"issue":"9","key":"10.1016\/j.ebiom.2019.11.046_bib0037","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1681\/ASN.2010070728","article-title":"Inhibition of the P2\u00a0\u00d7\u00a07 receptor reduces cystogenesis in PKD","volume":"22","author":"Chang","year":"2011","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"10.1016\/j.ebiom.2019.11.046_bib0038","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1681\/ASN.2010090956","article-title":"Suramin inhibits renal fibrosis in chronic kidney disease","volume":"22","author":"Liu","year":"2011","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"10.1016\/j.ebiom.2019.11.046_bib0039","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1515\/jtim-2016-0028","article-title":"Inhibition of cyst growth in PCK and Wpk rat models of polycystic kidney disease with low doses of peroxisome proliferator-activated receptor gamma agonists","volume":"4","author":"Flaig","year":"2016","journal-title":"J Transl Int Med"},{"key":"10.1016\/j.ebiom.2019.11.046_bib0040","doi-asserted-by":"crossref","DOI":"10.1155\/2010\/274376","article-title":"Pioglitazone attenuates cystic burden in the PCK rodent model of polycystic kidney disease","volume":"2010","author":"Blazer-Yost","year":"2010","journal-title":"PPAR Res"},{"issue":"8","key":"10.1016\/j.ebiom.2019.11.046_bib0041","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1042\/CS20100113","article-title":"Rosiglitazone attenuates development of polycystic kidney disease and prolongs survival in Han:SPRD rats","volume":"119","author":"Dai","year":"2010","journal-title":"Clin Sci (Lond)"},{"issue":"12","key":"10.1016\/j.ebiom.2019.11.046_bib0042","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1681\/ASN.2013020176","article-title":"Smac-mimetic-induced epithelial cell death reduces the growth of renal cysts","volume":"24","author":"Fan","year":"2013","journal-title":"J Am Soc Nephrol"},{"issue":"9","key":"10.1016\/j.ebiom.2019.11.046_bib0043","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1093\/ndt\/gfn144","article-title":"The effect of eicosapentaenoic acid on renal function and volume in patients with ADPKD","volume":"23","author":"Higashihara","year":"2008","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"10.1016\/j.ebiom.2019.11.046_bib0044","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1681\/ASN.2004080660","article-title":"Rapamycin markedly slows disease progression in a rat model of polycystic kidney disease","volume":"16","author":"Tao","year":"2005","journal-title":"J Am Soc Nephrol"},{"issue":"20","key":"10.1016\/j.ebiom.2019.11.046_bib0045","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1056\/NEJMoa1710030","article-title":"Tolvaptan in later-stage autosomal dominant polycystic kidney disease","volume":"377","author":"Torres","year":"2017","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.ebiom.2019.11.046_bib0046","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1038\/nm.3092","article-title":"Defective glucose metabolism in polycystic kidney disease identifies a new therapeutic strategy","volume":"19","author":"Rowe","year":"2013","journal-title":"Nat Med"},{"issue":"6","key":"10.1016\/j.ebiom.2019.11.046_bib0047","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1046\/j.1523-1755.2003.00023.x","article-title":"Cyclic AMP activates B-Raf and ERK in cyst epithelial cells from autosomal-dominant polycystic kidneys","volume":"63","author":"Yamaguchi","year":"2003","journal-title":"Kidney Int"},{"issue":"14","key":"10.1016\/j.ebiom.2019.11.046_bib0048","doi-asserted-by":"crossref","first-page":"5466","DOI":"10.1073\/pnas.0509694103","article-title":"The mTOR pathway is regulated by polycystin-1, and its inhibition reverses renal cystogenesis in polycystic kidney disease","volume":"103","author":"Shillingford","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"10","key":"10.1016\/j.ebiom.2019.11.046_bib0049","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1681\/ASN.2018050518","article-title":"Mcp1 promotes macrophage-dependent cyst expansion in autosomal dominant polycystic kidney disease","volume":"29","author":"Cassini","year":"2018","journal-title":"J Am Soc Nephrol"},{"issue":"9","key":"10.1016\/j.ebiom.2019.11.046_bib0050","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1681\/ASN.2018010074","article-title":"Interactions between macrophages and cyst-lining epithelial cells promote kidney cyst growth in Pkd1-deficient mice","volume":"29","author":"Yang","year":"2018","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"10.1016\/j.ebiom.2019.11.046_bib0051","doi-asserted-by":"crossref","first-page":"F806","DOI":"10.1152\/ajprenal.00653.2016","article-title":"Meta-analysis of polycystic kidney disease expression profiles defines strong involvement of injury repair processes","volume":"312","author":"Malas","year":"2017","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.ebiom.2019.11.046_bib0052","doi-asserted-by":"crossref","first-page":"144","DOI":"10.12688\/f1000research.2-144.v1","article-title":"High-resolution view of compound promiscuity","volume":"2","author":"Hu","year":"2013","journal-title":"F1000Res"},{"issue":"8","key":"10.1016\/j.ebiom.2019.11.046_bib0053","doi-asserted-by":"crossref","first-page":"e43965","DOI":"10.1371\/journal.pone.0043965","article-title":"Crystal structures of three classes of non-steroidal anti-inflammatory drugs in complex with aldo-keto reductase 1C3","volume":"7","author":"Flanagan","year":"2012","journal-title":"PLoS ONE"},{"issue":"5 Pt 2","key":"10.1016\/j.ebiom.2019.11.046_bib0054","first-page":"F791","article-title":"Coordinate regulation of 11 beta-HSD and Ke 6 genes in cpk mouse: implications for steroid metabolic defect in PKD","volume":"267","author":"Aziz","year":"1994","journal-title":"Am J Physiol"},{"issue":"1","key":"10.1016\/j.ebiom.2019.11.046_bib0055","doi-asserted-by":"crossref","first-page":"F122","DOI":"10.1152\/ajprenal.00352.2017","article-title":"PPARalpha agonist fenofibrate enhances fatty acid beta-oxidation and attenuates polycystic kidney and liver disease in mice","volume":"314","author":"Lakhia","year":"2018","journal-title":"Am J Physiol Renal Physiol"},{"issue":"4","key":"10.1016\/j.ebiom.2019.11.046_bib0056","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1158\/1078-0432.CCR-14-3156","article-title":"Effect of a smac mimetic (TL32711, birinapant) on the apoptotic program and apoptosis biomarkers examined with validated multiplex immunoassays fit for clinical use","volume":"22","author":"Srivastava","year":"2016","journal-title":"Clin Cancer Res"},{"issue":"1","key":"10.1016\/j.ebiom.2019.11.046_bib0057","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s40246-016-0095-x","article-title":"Transcriptome analysis reveals manifold mechanisms of cyst development in ADPKD","volume":"10","author":"de Almeida","year":"2016","journal-title":"Hum Genomics"},{"key":"10.1016\/j.ebiom.2019.11.046_bib0058","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/1752-0509-5-56","article-title":"Systems biology approach to identify transcriptome reprogramming and candidate microRNA targets during the progression of polycystic kidney disease","volume":"5","author":"Pandey","year":"2011","journal-title":"BMC Syst Biol"},{"issue":"11","key":"10.1016\/j.ebiom.2019.11.046_bib0059","doi-asserted-by":"crossref","first-page":"3404","DOI":"10.1681\/ASN.2016111232","article-title":"Bosutinib versus placebo for autosomal dominant polycystic kidney disease","volume":"28","author":"Tesar","year":"2017","journal-title":"J Am Soc Nephrol"},{"issue":"14","key":"10.1016\/j.ebiom.2019.11.046_bib0060","doi-asserted-by":"crossref","first-page":"3982","DOI":"10.1093\/hmg\/ddv136","article-title":"Therapeutic targeting of BET bromodomain protein, Brd4, delays cyst growth in ADPKD","volume":"24","author":"Zhou","year":"2015","journal-title":"Hum Mol Genet"},{"issue":"Suppl 1","key":"10.1016\/j.ebiom.2019.11.046_bib0061","doi-asserted-by":"crossref","first-page":"i27","DOI":"10.1093\/ckj\/sfy089","article-title":"Emerging targeted strategies for the treatment of autosomal dominant polycystic kidney disease","volume":"11","author":"Weimbs","year":"2018","journal-title":"Clin Kidney J"},{"issue":"31","key":"10.1016\/j.ebiom.2019.11.046_bib0062","doi-asserted-by":"crossref","first-page":"12786","DOI":"10.1073\/pnas.1301904110","article-title":"Inhibiting the HSP90 chaperone slows cyst growth in a mouse model of autosomal dominant polycystic kidney disease","volume":"110","author":"Seeger-Nukpezah","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"10.1016\/j.ebiom.2019.11.046_bib0063","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1681\/ASN.2009040421","article-title":"Rapamycin ameliorates PKD resulting from conditional inactivation of Pkd1","volume":"21","author":"Shillingford","year":"2010","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"10.1016\/j.ebiom.2019.11.046_bib0064","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1681\/ASN.2015060648","article-title":"Refining genotype-phenotype correlation in autosomal dominant polycystic kidney disease","volume":"27","author":"Hwang","year":"2016","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"10.1016\/j.ebiom.2019.11.046_bib0065","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s13321-017-0232-0","article-title":"Beyond the hype: deep neural networks outperform established methods using a ChEMBL bioactivity benchmark set","volume":"9","author":"Lenselink","year":"2017","journal-title":"J Cheminform"}],"container-title":["EBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396419307959?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396419307959?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T18:58:53Z","timestamp":1762455533000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396419307959"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":65,"alternative-id":["S2352396419307959"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2019.11.046","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.737136555.793571362","asserted-by":"object"}]},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prioritization of novel ADPKD drug candidates from disease-stage specific gene expression profiles","name":"articletitle","label":"Article Title"},{"value":"EBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2019.11.046","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"102585"}}